IGF-1 deficiency with age may increase sensitivity to damage in the brain and propensity for cognitive deficits and targeting mitochondrial function in the brain may be an avenue for therapy for age-related impairment of cognitive function. This evidence concerns the gene IGF1 and Cognitive impairment.